Hepatic resection following selective internal radiation therapy for colorectal cancer metastases in the FOXFIRE clinical trial: clinical outcomes and distribution of microspheres

Slični predmeti

• Hepatic resection following selective internal radiotherapy in the FOXFIRE clinical trial: survival, safety, and histopathology
  od: Virdee, PS, i dr.
  Izdano: (2018)
• FOXFIRE: a phase III clinical trial of chemo-radio-embolisation as first-line treatment of liver metastases in patients with colorectal cancer.
  od: Sharma, R, i dr.
  Izdano: (2008)
• Quality of life in the FOXFIRE, SIRFLOX, and FOXFIRE-Global randomised trials of selective internal radiotherapy for metastatic colorectal cancer
  od: Wolstenholme, J, i dr.
  Izdano: (2019)
• FOXFIRE-SIRFLOX-FOXFIRE global prospective randomised studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer: KRAS mutation and tumour site analysis
  od: Wasan, H, i dr.
  Izdano: (2017)
• O-027: Overall survival analysis of the FOXFIRE-SIRFLOX-FOXFIRE global prospective randomized studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer
  od: Wasan, H, i dr.
  Izdano: (2017)